Annual Operating Expenses
$67.83 M
+$14.33 M+26.78%
31 December 2023
Summary:
Astria Therapeutics annual total operating expenses is currently $67.83 million, with the most recent change of +$14.33 million (+26.78%) on 31 December 2023. During the last 3 years, it has risen by +$30.40 million (+81.20%). ATXS annual operating expenses is now at all-time high.ATXS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$29.01 M
+$211.00 K+0.73%
30 September 2024
Summary:
Astria Therapeutics quarterly total operating expenses is currently $29.01 million, with the most recent change of +$211.00 thousand (+0.73%) on 30 September 2024. Over the past year, it has increased by +$8.78 million (+43.38%). ATXS quarterly operating expenses is now at all-time high.ATXS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATXS Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.8% | +43.4% |
| 3 y3 years | +81.2% | +267.4% |
| 5 y5 years | +157.2% | +334.2% |
ATXS Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +123.4% | at high | +267.4% |
| 5 y | 5 years | at high | +157.2% | at high | +430.1% |
| alltime | all time | at high | +274.4% | at high | +549.2% |
Astria Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $29.01 M(+0.7%) |
| June 2024 | - | $28.80 M(+19.3%) |
| Mar 2024 | - | $24.15 M(+27.1%) |
| Dec 2023 | $67.83 M(+26.8%) | $19.00 M(-6.1%) |
| Sept 2023 | - | $20.24 M(+34.0%) |
| June 2023 | - | $15.10 M(+11.9%) |
| Mar 2023 | - | $13.49 M(-5.6%) |
| Dec 2022 | $53.50 M(+76.2%) | $14.29 M(+15.4%) |
| Sept 2022 | - | $12.39 M(+8.2%) |
| June 2022 | - | $11.45 M(-25.5%) |
| Mar 2022 | - | $15.38 M(+61.7%) |
| Dec 2021 | $30.36 M(-18.9%) | $9.51 M(+20.4%) |
| Sept 2021 | - | $7.90 M(+5.5%) |
| June 2021 | - | $7.49 M(+36.8%) |
| Mar 2021 | - | $5.47 M(-39.0%) |
| Dec 2020 | $37.44 M(+38.2%) | $8.98 M(-17.4%) |
| Sept 2020 | - | $10.86 M(+13.7%) |
| June 2020 | - | $9.55 M(+18.8%) |
| Mar 2020 | - | $8.04 M(+19.2%) |
| Dec 2019 | $27.09 M | $6.75 M(+1.0%) |
| Sept 2019 | - | $6.68 M(-8.8%) |
| June 2019 | - | $7.33 M(+15.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $6.33 M(+4.0%) |
| Dec 2018 | $26.37 M(-4.4%) | $6.09 M(+1.3%) |
| Sept 2018 | - | $6.01 M(-9.5%) |
| June 2018 | - | $6.64 M(-13.1%) |
| Mar 2018 | - | $7.64 M(+33.7%) |
| Dec 2017 | $27.59 M(-22.4%) | $5.71 M(-20.7%) |
| Sept 2017 | - | $7.20 M(+4.1%) |
| June 2017 | - | $6.92 M(-10.8%) |
| Mar 2017 | - | $7.76 M(-10.5%) |
| Dec 2016 | $35.56 M(+12.3%) | $8.67 M(+4.7%) |
| Sept 2016 | - | $8.28 M(-11.8%) |
| June 2016 | - | $9.40 M(+2.1%) |
| Mar 2016 | - | $9.21 M(-1.4%) |
| Dec 2015 | $31.66 M(+46.0%) | $9.33 M(+13.8%) |
| Sept 2015 | - | $8.20 M(+5.6%) |
| June 2015 | - | $7.76 M(+22.1%) |
| Mar 2015 | - | $6.36 M(+8.2%) |
| Dec 2014 | $21.68 M(+19.7%) | $5.88 M(-1.6%) |
| Sept 2014 | - | $5.97 M(+11.3%) |
| June 2014 | - | $5.36 M(+20.0%) |
| Mar 2014 | - | $4.47 M |
| Dec 2013 | $18.12 M | - |
FAQ
- What is Astria Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Astria Therapeutics?
- What is Astria Therapeutics annual operating expenses year-on-year change?
- What is Astria Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Astria Therapeutics?
- What is Astria Therapeutics quarterly operating expenses year-on-year change?
What is Astria Therapeutics annual total operating expenses?
The current annual operating expenses of ATXS is $67.83 M
What is the all time high annual operating expenses for Astria Therapeutics?
Astria Therapeutics all-time high annual total operating expenses is $67.83 M
What is Astria Therapeutics annual operating expenses year-on-year change?
Over the past year, ATXS annual total operating expenses has changed by +$14.33 M (+26.78%)
What is Astria Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of ATXS is $29.01 M
What is the all time high quarterly operating expenses for Astria Therapeutics?
Astria Therapeutics all-time high quarterly total operating expenses is $29.01 M
What is Astria Therapeutics quarterly operating expenses year-on-year change?
Over the past year, ATXS quarterly total operating expenses has changed by +$8.78 M (+43.38%)